Intestinal Research

IBD
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review: Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel, Gordon William Moran; Intest Res. 2019;17(2):160-170. Published online February 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00114
Web of Science 36 Crossref 36; Full text PubReader ePub PDF Supplementary Material

Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients: Marcello Rabello Imbrizi, Daniela Oliveira Magro, Tirzah de Mendonça Lopes Secundo, Marlone Cunha-Silva, Paulo Gustavo Kotze, Ciro Garcia Montes, Jazon Romilson de Souza Almeida, Virgínia Lúcia Ribeiro Cabral; Intest Res. 2019;17(1):63-69. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00077
Web of Science 9 Crossref 9; Full text PubReader ePub PDF

Clinical aspects and treatments for pediatric inflammatory bowel disease: Jin Soo Moon; Intest Res. 2019;17(1):17-23. Published online January 9, 2019; DOI: https://doi.org/10.5217/ir.2018.00139
Web of Science 15 Crossref 14; Full text PubReader ePub PDF

An overview of the role of exclusive enteral nutrition for complicated Crohn’s disease: Mustafa Adamji, Andrew S Day; Intest Res. 2019;17(2):171-176. Published online December 3, 2018; DOI: https://doi.org/10.5217/ir.2018.00079
Web of Science 21 Crossref 23; Full text PubReader ePub PDF

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies: Rintaro Moroi, Katsuya Endo, Katsutoshi Yamamoto, Takeo Naito, Motoyuki Onodera, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Yoichi Kakuta, Atsushi Masamune, Yoshitaka Kinouchi, Tooru Shimosegawa; Intest Res. 2019;17(1):94-106. Published online December 3, 2018; DOI: https://doi.org/10.5217/ir.2018.00048
Web of Science 8 Crossref 8; Full text PubReader ePub PDF Supplementary Material

Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study: Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei; Intest Res. 2019;17(1):54-62. Published online November 20, 2018; DOI: https://doi.org/10.5217/ir.2018.00096
Web of Science 94 Crossref 98; Full text PubReader ePub PDF

Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?: Jeongseok Kim, Byong Duk Ye; Intest Res. 2019;17(1):24-35. Published online November 12, 2018; DOI: https://doi.org/10.5217/ir.2018.00128
Crossref 2; Full text PubReader ePub PDF

Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease: Hyeon-A Kim, Hyo-rim Suh, Ben Kang, Byung-Ho Choe, on behalf of Crohn’s and Colitis Association in DaeguGyeongbuk (CCAiD); Intest Res. 2019;17(1):144-148. Published online October 16, 2018; DOI: https://doi.org/10.5217/ir.2018.00104
Web of Science 4 Crossref 3; Full text PubReader ePub PDF

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India: Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja; Intest Res. 2018;16(4):588-598. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00023
Web of Science 29 Crossref 35; Full text PubReader ePub PDF

Medication non-adherence in inflammatory bowel diseases is associated with disability: Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong; Intest Res. 2018;16(4):571-578. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00033
Web of Science 29 Crossref 31; Full text PubReader ePub PDF

Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study: Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh; Intest Res. 2018;16(4):554-562. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00027
Web of Science 4 Crossref 3; Full text PubReader ePub PDF

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring: Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong; Intest Res. 2018;16(4):546-553. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00052
Web of Science 19 Crossref 20; Full text PubReader ePub PDF

IBD2020 global forum: results of an international patient survey on quality of care: Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis; Intest Res. 2018;16(4):537-545. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00041
Web of Science 17 Crossref 19; Full text PubReader ePub PDF Supplementary Material

Magnetic resonance enterography predicts the prognosis of Crohn's disease: Ji Hoon Lee, Yong Eun Park, Nieun Seo, Hyun Jung Lee, Soo Jung Park, Tae Il Kim, Won Ho Kim, Joon Seok Lim, Jae Hee Cheon; Intest Res. 2018;16(3):445-457. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.445
Web of Science 9 Crossref 9; Full text PubReader ePub PDF

What nutritional factors influence bone mineral density in Crohn's disease patients?: Fernanda Gomes Coqueiro, Raquel Rocha, Camilla Almeida Menezes, Mirella Brasil Lopes, Vanessa Rosa Oliveira, Flora Maria Lorenzo Fortes, Genoile Oliveira Santana; Intest Res. 2018;16(3):436-444. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.436
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Search